Zenoks Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 12.79%
- Profit Growth 120.24%
- Ebitda 124.87%
- Net Worth 6.77%
- Total Assets 0.27%
About Zenoks Biotech
Zenoks Biotech Private Limited (ZBPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 May 2010 and has a history of 14 years and nine months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mala Poddar and Murari Poddar serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230GJ2010PTC060795
- Company No.
060795
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 May 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Zenoks Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mala Poddar  | Director | 18-May-2010 | Current |
| Murari Poddar | Director | 18-May-2010 | Current |
Financial Performance of Zenoks Biotech.
Zenoks Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.79% increase. The company also saw a substantial improvement in profitability, with a 120.24% increase in profit. The company's net worth moved up by a moderate rise of 6.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenoks Biotech?
In 2023, Zenoks Biotech had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Axis Wellness Private LimitedMala Poddar and Murari Poddar are mutual person
Axis Life Science Private LimitedMala Poddar and Murari Poddar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zenoks Biotech?
Unlock and access historical data on people associated with Zenoks Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenoks Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenoks Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
